리서치사:Market Glass, Inc. (Formerly Global Industry Analysts, Inc.)
발행일:2024년 09월
페이지 정보:영문 193 Pages
라이선스 & 가격 (부가세 별도)
한글목차
어레이 장비 세계 시장은 2030년까지 27억 달러에 달할 것으로 전망
2023년 19억 달러로 추정되는 어레이 장비 세계 시장은 2023-2030년 분석 기간 동안 연평균 5.3% 성장하여 2030년에는 27억 달러에 달할 것으로 예상됩니다. 본 보고서에서 분석한 부문 중 하나인 DNA 마이크로어레이 기술은 CAGR 5.4%를 기록하여 분석 기간 종료 시점에 14억 달러에 도달할 것으로 예상됩니다. 단백질 마이크로어레이 기술 분야의 성장률은 분석 기간 동안 CAGR 5.8%로 추정됩니다.
미국 시장 5억 760만 달러로 추정, 중국은 CAGR 5.1%로 성장 전망
미국 어레이 장비 시장은 2023년 5억 760만 달러로 추정됩니다. 세계 2위의 경제 대국인 중국은 2023년부터 2030년까지 연평균 5.1%의 성장률을 보이며 2030년에는 4억 2,270만 달러의 시장 규모에 도달할 것으로 예상됩니다. 다른 주목할 만한 지역 시장으로는 일본과 캐나다가 있으며, 분석 기간 동안 각각 5.1%와 4.1%의 CAGR을 기록할 것으로 예상됩니다. 유럽에서는 독일이 4.4%의 CAGR로 성장할 것으로 예상됩니다.
세계 어레이 장비 시장 - 주요 동향 및 촉진요인 정리
어레이 장비는 어떻게 생물 의학 연구에 혁명을 일으키고 있는가?
어레이 장비는 복잡한 생물학적 데이터를 분석할 수 있는 전례 없는 능력을 제공하며, DNA 마이크로어레이, 단백질 어레이, 조직 어레이 등 생물 의학 연구 분야에서 없어서는 안 될 도구로 자리 잡았습니다. 수천 개의 유전자, 단백질 및 기타 생체 분자의 발현을 동시에 조사할 수 있습니다. 어레이 장비의 높은 처리량은 과학자들이 유전체학, 단백질체학, 맞춤의료에 접근하는 방식을 변화시켜 보다 포괄적이고 정확한 분석이 가능해졌습니다. 어레이 장비는 여러 바이오마커를 동시에 조사하는 것을 용이하게함으로써 암 연구, 유전자 질환, 의약품 개발 등의 분야에서 발견의 속도를 가속화했습니다. 유전자 발현 패턴과 단백질 상호 작용을 빠르고 정확하게 평가할 수 있는 이 장비는 현대 실험실 작업의 핵심이 되어 질병 메커니즘과 잠재적 치료 표적에 대한 이해에 큰 진전을 가져왔습니다.
어레이 장비의 성능을 향상시키는 기술 혁신이란?
어레이 장비의 진화는 끊임없는 기술 혁신을 통해 그 기능과 응용 범위를 확장해 왔습니다. 최근 마이크로어레이 기술의 발전은 이러한 장비의 민감도, 특이성 및 해상도를 향상시켜 유전자 및 단백질 발현의 미세한 변화도 감지할 수 있게 되었습니다. 또한 고급 계산 도구의 통합으로 데이터 분석 능력이 향상되어 연구자들이 복잡한 데이터 세트를 보다 정확하고 효율적으로 해석할 수 있게 되었습니다. 고밀도 어레이 개발과 같은 어레이 설계의 혁신은 이러한 장비의 처리량을 더욱 향상시켜 그 어느 때보다 강력해졌습니다. 또한, 여러 종류의 생체 분자를 동시에 분석할 수 있는 다중화 어레이의 출현은 특히 시스템 생물학 분야에서 새로운 연구의 길을 열었습니다. 이러한 기술의 발전은 어레이 장비의 성능을 향상시켰을 뿐만 아니라 응용 범위를 넓혀 기초 과학에서 임상 진단에 이르기까지 광범위한 연구 분야에서 필수 불가결한 요소로 자리 잡았습니다.
왜 어레이 장비가 개인 맞춤형 의료 및 진단에 중요한가?
어레이 장비는 정밀도와 정확성이 가장 중요한 개인 맞춤형 의료와 진단학의 발전에 있어 매우 중요한 역할을 하고 있습니다. 어레이 장비는 개별 환자의 상세한 분자 프로파일을 제공할 수 있기 때문에 질병을 진단하고 치료하는 방식에 혁명을 일으켰습니다. 맞춤의료에서 어레이 장비는 특정 치료에 대한 환자의 반응을 예측할 수 있는 특정 유전자 돌연변이 및 발현 패턴을 식별하는 데 사용되어 보다 맞춤화되고 효과적인 치료 전략을 가능하게 합니다. 진단에서는 암, 심혈관질환, 자가면역질환 등 질병의 유무와 진행을 나타내는 바이오마커를 검출할 수 있습니다. 임상 현장에서 어레이 장비의 도입은 획일적인 치료에서 개인 맞춤형 치료로의 전환을 촉진하고, 환자 결과를 개선하며, 의료 비용을 절감할 수 있습니다. 개인화된 헬스케어 솔루션에 대한 수요가 지속적으로 증가함에 따라 연구와 임상 모두에서 어레이 장비의 중요성이 크게 증가할 것으로 예상됩니다.
어레이 장비 시장의 성장 원동력은?
어레이 장비 시장의 성장은 여러 가지 요인에 의해 성장과 진화를 주도하고 있습니다. 가장 큰 원동력은 대규모 데이터 세트를 빠르고 정확하게 분석해야 하는 생의학 연구 분야에서 높은 처리량 기술에 대한 수요가 증가하고 있다는 점입니다. 또한, 개인 맞춤형 의료의 부상도 시장 성장에 크게 기여하고 있습니다. 의료 서비스 제공자들이 분자진단 및 맞춤형 치료 전략을 위한 첨단 도구를 찾고 있기 때문입니다. 차세대 마이크로어레이의 개발, 데이터 분석에 AI와 머신러닝의 통합과 같은 기술 발전은 이러한 기기의 기능과 효율성을 향상시켜 시장을 더욱 촉진하고 있습니다. 암 연구, 의약품 개발, 농업 생명공학 등의 분야에서 어레이 장비의 적용이 확대되면서 시장 성장의 새로운 기회를 창출하고 있습니다. 또한, 질병의 조기 발견과 정밀의료의 발전이 강조되면서, 특히 의료 인프라가 잘 갖춰진 선진국에서는 임상 진단에 어레이 장비의 채택이 증가하고 있습니다. 이러한 추세에 따라 어레이 장비 시장은 혁신과 연구 및 의료 분야의 고급 분석 도구에 대한 수요 증가로 인해 지속적인 성장을 이룰 수 있는 여건이 조성되고 있습니다.
조사 대상 기업 예시(총 43건)
Affymetrix, Inc.
Agilent Technologies, Inc.
Arrayit Corporation
Bio-Rad Laboratories, Inc.
Illumina, Inc.
Laboratory Corporation of America Holdings(LabCorp)
Luminex Corporation
Meso Scale Diagnostics, LLC.
MilliporeSigma
Mingyuan Medicare Development Company Limited
Molecular Devices LLC
Novus Biologicals LLC
OriGene Technologies, Inc.
Orla Protein Technologies Ltd.
Oxford Gene Technology
Partek, Inc.
Pepscan
PerkinElmer, Inc.
Phalanx Biotech Group
ProteoGenix
Qiagen NV
RayBiotech, Inc.
Retrogenix Ltd.
Thermo Fisher Scientific, Inc.
목차
제1장 조사 방법
제2장 주요 요약
시장 개요
주요 기업
시장 동향과 성장 촉진요인
세계 시장 전망
제3장 시장 분석
미국
캐나다
일본
중국
유럽
프랑스
독일
이탈리아
영국
기타 유럽
아시아태평양
기타 지역
제4장 경쟁
ksm
영문 목차
영문목차
Global Array Instruments Market to Reach US$2.7 Billion by 2030
The global market for Array Instruments estimated at US$1.9 Billion in the year 2023, is expected to reach US$2.7 Billion by 2030, growing at a CAGR of 5.3% over the analysis period 2023-2030. DNA Microarrays Technology, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$1.4 Billion by the end of the analysis period. Growth in the Protein Microarrays Technology segment is estimated at 5.8% CAGR over the analysis period.
The U.S. Market is Estimated at US$507.6 Million While China is Forecast to Grow at 5.1% CAGR
The Array Instruments market in the U.S. is estimated at US$507.6 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$422.7 Million by the year 2030 trailing a CAGR of 5.1% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.1% and 4.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.4% CAGR.
Global Array Instruments Market - Key Trends and Drivers Summarized
How Are Array Instruments Revolutionizing Biomedical Research?
Array instruments have become indispensable tools in the field of biomedical research, offering unprecedented capabilities in analyzing complex biological data. These instruments, which include DNA microarrays, protein arrays, and tissue arrays, enable researchers to study the expression of thousands of genes, proteins, or other biomolecules simultaneously. The high-throughput nature of array instruments has transformed the way scientists approach genomics, proteomics, and personalized medicine, allowing for more comprehensive and precise analyses. By facilitating the simultaneous examination of multiple biomarkers, array instruments have accelerated the pace of discovery in areas such as cancer research, genetic disorders, and drug development. The ability to quickly and accurately assess gene expression patterns and protein interactions has made these instruments a cornerstone of modern laboratory practices, leading to significant advancements in our understanding of disease mechanisms and potential therapeutic targets.
What Technological Innovations Are Enhancing the Capabilities of Array Instruments?
The evolution of array instruments has been driven by continuous technological innovations that have expanded their functionality and application scope. Recent advancements in microarray technology have increased the sensitivity, specificity, and resolution of these instruments, enabling the detection of even minute changes in gene or protein expression. Additionally, the integration of advanced computational tools has enhanced data analysis capabilities, allowing researchers to interpret complex datasets with greater accuracy and efficiency. Innovations in array design, such as the development of high-density arrays, have further increased the throughput of these instruments, making them more powerful than ever before. Moreover, the emergence of multiplexed arrays, which can analyze multiple types of biomolecules simultaneously, has opened new avenues for research, particularly in the field of systems biology. These technological strides have not only improved the performance of array instruments but have also broadened their applicability, making them essential in a wide range of research areas, from basic science to clinical diagnostics.
Why Are Array Instruments Critical in Personalized Medicine and Diagnostics?
Array instruments play a pivotal role in the advancement of personalized medicine and diagnostics, where precision and accuracy are paramount. The ability of these instruments to provide detailed molecular profiles of individual patients has revolutionized the way diseases are diagnosed and treated. In personalized medicine, array instruments are used to identify specific genetic mutations or expression patterns that can predict a patient’s response to certain therapies, allowing for more tailored and effective treatment strategies. In diagnostics, these instruments enable the detection of biomarkers that can indicate the presence or progression of diseases such as cancer, cardiovascular conditions, and autoimmune disorders. The adoption of array instruments in clinical settings has facilitated the transition from one-size-fits-all treatment approaches to more individualized care, improving patient outcomes and reducing healthcare costs. As the demand for personalized healthcare solutions continues to grow, the importance of array instruments in both research and clinical practice is expected to increase significantly.
What Is Driving the Growth of the Array Instruments Market?
The growth in the array instruments market is driven by several factors that are shaping its expansion and evolution. A key driver is the increasing demand for high-throughput technologies in biomedical research, where the need to analyze large datasets quickly and accurately is paramount. The rise of personalized medicine has also significantly contributed to market growth, as healthcare providers seek advanced tools for molecular diagnostics and tailored treatment strategies. Technological advancements, such as the development of next-generation microarrays and the integration of AI and machine learning in data analysis, are further propelling the market by enhancing the capabilities and efficiency of these instruments. The expanding application of array instruments in areas such as cancer research, drug development, and agricultural biotechnology is creating new opportunities for market growth. Additionally, the growing emphasis on early disease detection and the development of precision medicine are driving the adoption of array instruments in clinical diagnostics, particularly in developed countries with advanced healthcare infrastructures. As these trends continue to evolve, the array instruments market is poised for sustained growth, driven by innovation and the expanding need for sophisticated analytical tools in both research and healthcare.
Select Competitors (Total 43 Featured) -
Affymetrix, Inc.
Agilent Technologies, Inc.
Arrayit Corporation
Bio-Rad Laboratories, Inc.
Illumina, Inc.
Laboratory Corporation of America Holdings (LabCorp)
Luminex Corporation
Meso Scale Diagnostics, LLC.
MilliporeSigma
Mingyuan Medicare Development Company Limited
Molecular Devices LLC
Novus Biologicals LLC
OriGene Technologies, Inc.
Orla Protein Technologies Ltd.
Oxford Gene Technology
Partek, Inc.
Pepscan
PerkinElmer, Inc.
Phalanx Biotech Group
ProteoGenix
Qiagen NV
RayBiotech, Inc.
Retrogenix Ltd.
Thermo Fisher Scientific, Inc.
TABLE OF CONTENTS
I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Array Instruments - Global Key Competitors Percentage Market Share in 2024 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
Global Economic Update
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Demand for High-Throughput Technologies Spurs Growth of Array Instruments
Technological Advancements in Microarray Design Expands Addressable Market Opportunity
Increasing Application in Cancer Research Propels Growth in Array Instruments Market
Advancements in Multiplexed Arrays Generate Opportunities for Systems Biology Research
Growing Focus on Early Disease Detection Throws the Spotlight on Clinical Diagnostics
Expansion of Genomic Research Drives Adoption of Next-Generation Microarrays
Growing Need for Comprehensive Biomarker Analysis Drives Innovation in Array Technologies
Increased Use of Arrays in Agricultural Biotechnology Expands Application Scope
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for R&D Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 2: World Historic Review for R&D Laboratories by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 3: World 16-Year Perspective for R&D Laboratories by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Clinical Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 5: World Historic Review for Clinical Diagnostic Labs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 6: World 16-Year Perspective for Clinical Diagnostic Labs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 8: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 9: World 16-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 10: World Array Instruments Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
TABLE 11: World Recent Past, Current & Future Analysis for Array Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 12: World Historic Review for Array Instruments by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 13: World 16-Year Perspective for Array Instruments by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2024 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for DNA Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 15: World Historic Review for DNA Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 16: World 16-Year Perspective for DNA Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 17: World Recent Past, Current & Future Analysis for Protein Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 18: World Historic Review for Protein Microarrays by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 19: World 16-Year Perspective for Protein Microarrays by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 21: World Historic Review for Other Technologies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 22: World 16-Year Perspective for Other Technologies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2024 & 2030
III. MARKET ANALYSIS
UNITED STATES
Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
TABLE 23: USA Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 24: USA Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 25: USA 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 26: USA Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 27: USA Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 28: USA 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
CANADA
TABLE 29: Canada Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 30: Canada Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 31: Canada 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 32: Canada Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 33: Canada Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 34: Canada 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
JAPAN
Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
TABLE 35: Japan Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 36: Japan Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 37: Japan 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 38: Japan Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 39: Japan Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 40: Japan 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
CHINA
Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
TABLE 41: China Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 42: China Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 43: China 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 44: China Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 45: China Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 46: China 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
EUROPE
Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
TABLE 47: Europe Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 48: Europe Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 49: Europe 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 50: Europe Recent Past, Current & Future Analysis for Array Instruments by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
TABLE 51: Europe Historic Review for Array Instruments by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 52: Europe 16-Year Perspective for Array Instruments by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2024 & 2030
TABLE 53: Europe Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 54: Europe Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 55: Europe 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
FRANCE
Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
TABLE 56: France Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 57: France Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 58: France 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 59: France Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 60: France Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 61: France 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
GERMANY
Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
TABLE 62: Germany Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 63: Germany Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 64: Germany 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 65: Germany Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 66: Germany Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 67: Germany 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
ITALY
TABLE 68: Italy Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 69: Italy Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 70: Italy 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 71: Italy Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 72: Italy Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 73: Italy 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
UNITED KINGDOM
Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
TABLE 74: UK Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 75: UK Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 76: UK 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 77: UK Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 78: UK Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 79: UK 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
REST OF EUROPE
TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 81: Rest of Europe Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 82: Rest of Europe 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 84: Rest of Europe Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 85: Rest of Europe 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
ASIA-PACIFIC
Array Instruments Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 87: Asia-Pacific Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 88: Asia-Pacific 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 90: Asia-Pacific Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 91: Asia-Pacific 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030
REST OF WORLD
TABLE 92: Rest of World Recent Past, Current & Future Analysis for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 93: Rest of World Historic Review for Array Instruments by End-Use - R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 94: Rest of World 16-Year Perspective for Array Instruments by End-Use - Percentage Breakdown of Value Sales for R&D Laboratories, Clinical Diagnostic Labs and Other End-Uses for the Years 2014, 2024 & 2030
TABLE 95: Rest of World Recent Past, Current & Future Analysis for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
TABLE 96: Rest of World Historic Review for Array Instruments by Technology - DNA Microarrays, Protein Microarrays and Other Technologies Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
TABLE 97: Rest of World 16-Year Perspective for Array Instruments by Technology - Percentage Breakdown of Value Sales for DNA Microarrays, Protein Microarrays and Other Technologies for the Years 2014, 2024 & 2030